先看重点
汇总27项随机对照试验,手机应用辅助的自我管理与HbA1c降低(标准化均数差-0.44,95%置信区间-0.59至-0.29)以及收缩压、舒张压的小幅下降(标准化均数差均为-0.17)相关。效应以标准化单位表示,摘要未报告异质性。
证据类型
随机试验荟萃分析
解读依据
公开摘要
阅读重点
方法与适用范围
研究在问什么
手机应用有望支持2型糖尿病和高血压患者的自我管理,但证据仍需加强。作者检验了应用辅助的自我管理能否改善患者结局,以及哪些应用功能与更好的效果相关。
研究了谁,如何研究
遵循Cochrane协作网指南的随机对照试验系统综述和荟萃分析。检索MEDLINE、Cochrane图书馆、EMBASE和CINAHL Plus中2007年1月至2019年1月发表的研究。主要结局为HbA1c、收缩压(SBP)和舒张压(DBP)的变化,其他结局为次要结局。至少2项试验报告的结局进行荟萃分析,否则做叙述性综合。共纳入27项试验。
主要发现
以下为作者报告的结果。数字须连同人群和不确定性一起阅读。
- 1应用辅助的自我管理使HbA1c显著下降(标准化均数差-0.44;95%置信区间-0.59至-0.29;P<.001)。
- 2收缩压下降(标准化均数差-0.17;95%置信区间-0.31至-0.03;P=.02),舒张压也下降(标准化均数差-0.17;95%置信区间-0.30至-0.03;P=.02)。
- 3在做荟萃分析的8项客观次要结局中,空腹血糖和腰围显著下降;另有42项次要结局做了叙述性综合,结果不一。
- 4与更好自我管理相关的功能包括血糖、血压和用药监测,与医疗人员沟通,自动反馈,个性化目标,提醒,健康教育和数据可视化。
局限与不确定性
- 1效应以标准化均数差表示,难以换算成实际的HbA1c或mm Hg变化,且血压效应较小。
- 2摘要没有说明试验质量和试验间异质性,这些估计的可信度不明。
- 3关于功能的结论来自亚组分析,作为应用起效因素的证据较弱。
- 4作者指出,行为、知识和心理社会结局方面的证据仍然不足。本文解读仅基于摘要。
对日常健康的启示
对于已在管理2型糖尿病或高血压的人,一款设计良好的自我管理应用,尤其是带有反馈并能联系医疗团队的,或许有小幅帮助。它不能替代医疗,也不能作为调整药物的依据。使用哪些工具,可与医生讨论。
如何联系自己的数据
如果你有血糖仪或血压计,在固定时间把读数记入应用,并把趋势分享给医生,这与试验中发现有用的功能相符。比较读数时请使用同一设备和同一流程,重点看整体趋势。
如何理解这类证据
合并试验可提高精度,但人群、对照、偏倚与不确定性仍重要;网络排名包含间接证据,不是通用最佳方案。
作者的结构化摘要 English
以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。
Background
Mobile app-assisted self-care interventions are emerging promising tools to support self-care of patients with chronic diseases such as type 2 diabetes and hypertension. The effectiveness of such interventions requires further exploration for more supporting evidence.
Objective
A systematic review and meta-analysis of randomized controlled trials (RCTs) were conducted to examine the effectiveness of mobile app-assisted self-care interventions developed for type 2 diabetes and/or hypertension in improving patient outcomes.
Methods
We followed the Cochrane Collaboration guidelines and searched MEDLINE, Cochrane Library, EMBASE, and CINAHL Plus for relevant studies published between January 2007 and January 2019. Primary outcomes included changes in hemoglobin A_(1c) (HbA_(1c)) levels, systolic blood pressure (SBP), and diastolic blood pressure (DBP). Changes in other clinical-, behavioral-, knowledge-, and psychosocial-related outcomes were included as secondary outcomes. Primary outcomes and objective secondary outcomes that were reported in at least two trials were meta-analyzed; otherwise, a narrative synthesis was used for data analysis.
Results
A total of 27 trials were identified and analyzed. For primary outcomes, the use of mobile app-assisted self-care interventions was associated with significant reductions in HbA_(1c) levels (standardized mean difference [SMD] -0.44, 95% CI -0.59 to -0.29; P<.001), SBP (SMD -0.17, 95% CI -0.31 to -0.03, P=.02), and DBP (SMD -0.17, 95% CI -0.30 to -0.03, P=.02). Subgroup analyses for primary outcomes showed that several intervention features were supportive of self-management, including blood glucose, blood pressure, and medication monitoring, communication with health care providers, automated feedback, personalized goal setting, reminders, education materials, and data visualization. In addition, 8 objective secondary outcomes were meta-analyzed, which showed that the interventions had significant lowering effects on fasting blood glucose levels and waist circumference. A total of 42 secondary outcomes were narratively synthesized, and mixed results were found.
Conclusions
Mobile app-assisted self-care interventions can be effective tools for managing blood glucose and blood pressure, likely because their use facilitates remote management of health issues and data, provision of personalized self-care recommendations, patient-care provider communication, and decision making. More studies are required to further determine which combinations of intervention features are most effective in improving the control of the diseases. Moreover, evidence regarding the effects of these interventions on the behavioral, knowledge, and psychosocial outcomes of patients is still scarce, which warrants further examination.
来源与署名
Effectiveness of Mobile App-Assisted Self-Care Interventions for Improving Patient Outcomes in Type 2 Diabetes and/or Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Liu K, Xie Z, Or CK.
JMIR mHealth and uHealth · 2020-08-04
DOI: 10.2196/15779 ↗PubMed · 32459654 ↗Europe PMC · 记录的开放许可: cc by ↗摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。
MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅
来源核验日期 2026-11-01
实用健康指南
放在一起读
昼夜活动节律紊乱与更高的死亡风险相关(109,365人)
在7项观察性研究、共109,365名参与者中,昼夜活动对比较弱(相对振幅较低)与更高的心血管死亡风险(风险比[HR]1.50,95%置信区间1.13至1.98)和全因死亡风险(HR 1.46,95%置信区间1.27至1.68)相关。证据基础小,又是观察性的,不能说明改善节律就能降低风险,疾病本身也可能扰乱节律。
Journal of the American Heart Association
五类运动都降低了静息血压,等长训练降幅最大
汇总270项随机试验、共15,827名参与者的结果,有氧、抗阻、联合、间歇和等长训练与无干预对照组相比都降低了静息血压(各P<0.001),其中等长训练降幅最大:收缩压下降8.24 mm Hg,舒张压下降4.00 mm Hg。各方式之间的排序部分来自间接比较,各试验也不尽相同,所以排序不是个人的运动处方。
British Journal of Sports Medicine
盐替代品使中国农村高危人群的卒中、主要心血管事件和死亡率下降
在中国农村600个村庄、20,995名有卒中史或年龄在60岁及以上且有高血压的人中,使用盐替代品(氯化钠75%、氯化钾25%)的卒中发生率低于普通盐:平均随访4.74年,每1000人年29.14次对33.65次(率比0.86,95%置信区间0.77至0.96;P=0.006)。死亡也更低(率比0.88),严重高钾血症事件没有显著增多,但试验为开放标签设计,且在中国农村开展。
The New England Journal of Medicine
智能手表脉搏不规则提醒较少见,做贴片检查者34%确有房颤
在419,297名没有已知心房颤动(房颤)的苹果手表用户中,0.52%收到脉搏不规则提醒;返还可用心电贴片的450人中,34%确认有房颤(97.5%置信区间29至39)。提醒发出时恰有贴片记录的,通知的阳性预测值为0.84(95%置信区间0.76至0.92),但收到提醒者中仅20.8%返还了贴片,没有收到提醒的人未被监测,所以手表没有提醒并不能排除房颤。
The New England Journal of Medicine

